Back

Refining risk in cancer patients with coronary artery disease: do ARC-HBR criteria deliver?

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Coronary disease and cardiovascular toxicity in patients with cancer Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Catarina Silva

Centro Hospitalar Universitário Lisboa Norte, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Liraglutide reduces myocardial metalloproteinase 2 activity without attenuating doxorubicin-induced cardiac dysfunction in rats
Doctor C. Rodrigues Tonon (Botucatu, BR)
Abstract Slides
Presentation thumbnail
Cancer-specific mortality after acute coronary syndrome: insights from a nationwide real-world cohort
Miss M. Li (Suzhou, CN)
Abstract Slides
Presentation thumbnail
Cardiovascular adverse events in newly diagnosed multiple myeloma: incidence, predictors, and prognostic impact
Professor D. Zhao (Dalian, CN)
Abstract Slides
Presentation thumbnail
Construction and validation of a nomogram prediction model for myocardial injury in breast cancer patients after treatment
Professor Y. Zhang (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Residual cardiovascular risk after ACS in oncologic patients: the prognostic role of persistently elevated NT proBNP.
Doctor A. Denegri (Parma, IT) Doctor F. Wenzl (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Coronary disease and cardiovascular toxicity in patients with cancer

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Implications of ESC-high tthrombotic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI
29 August 2021
thumbnail
Congress Presentation
Improving cardio oncology care: the experience of two institutes
21 June 2025
thumbnail
Congress Presentation
Clinical implications of immunonutritional status in cancer patients undergoing percutaneous coronary intervention: insights from the SAKURA PCI2 Antithrombotic Registry
29 August 2025
thumbnail
Congress Presentation
Features and predictors of 1-year outcomes in cancer patients discharged after acute coronary syndrome: insights from a multicenter registry.
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources